Sun Pharmaceutical Industries and Ranbaxy Inc.

Alleged price fixing of generic and branded versions of Nexium, Diovan, and Valcyte affecting third-party payors across the U.S. and specified states.

This settlement resolves claims that Sun Pharmaceutical Industries and Ranbaxy Inc. conspired to fix prices on generic Nexium, Diovan, and Valcyte products sold nationwide and in certain states between 2012 and 2020.

• Third-party payors who purchased or paid for AB-rated generic Nexium in the U.S. or specified states between May 27, 2014 and Feb 1, 2019.
• Third-party payors who purchased or paid for Diovan or AB-rated generic versions in the U.S. or specified states between Sept 28, 2012 and April 1, 2020.
• Third-party payors who purchased or paid for Valcyte or AB-rated generic versions in the U.S. or specified states between Aug 1, 2014 and April 1, 2020.